Beta-ureidopropionase is an
enzyme that in humans is encoded by the UPB1gene.[5][6]
This gene encodes a protein that belongs to the CN hydrolase family. Beta-ureidopropionase catalyzes the last step in the pyrimidine degradation pathway. The pyrimidine bases
uracil and
thymine are degraded via the consecutive action of
dihydropyrimidine dehydrogenase (DHPDH),
dihydropyrimidinase (DHP) and
beta-ureidopropionase (UP) to
beta-alanine and
beta-aminoisobutyric acid, respectively. UP deficiencies are associated with N-carbamyl-beta-amino aciduria and may lead to abnormalities in neurological activity.[6]
Interactive pathway map
Click on genes, proteins and metabolites below to link to respective articles.[§ 1]
Thomas HR, Ezzeldin HH, Guarcello V, et al. (2008). "Genetic regulation of beta-ureidopropionase and its possible implication in altered uracil catabolism". Pharmacogenet. Genomics. 18 (1): 25–35.
doi:
10.1097/FPC.0b013e3282f2f134.
PMID18216719.
S2CID10940058.
Thomas HR, Ezzeldin HH, Guarcello V, et al. (2008). "Genetic regulation of dihydropyrimidinase and its possible implication in altered uracil catabolism". Pharmacogenet. Genomics. 17 (11): 973–87.
doi:
10.1097/FPC.0b013e3282f01788.
PMID18075467.
S2CID23490646.
van Kuilenburg AB, Meinsma R, Assman B, et al. (2007). "Genetic analysis of the first 4 patients with beta-ureidopropionase deficiency". Nucleosides Nucleotides Nucleic Acids. 25 (9–11): 1093–8.
doi:
10.1080/15257770600956870.
PMID17065070.
S2CID34904943.
Naguib FN, el Kouni MH, Cha S (1985). "Enzymes of uracil catabolism in normal and neoplastic human tissues". Cancer Res. 45 (11 Pt 1): 5405–12.
PMID3931905.
Beta-ureidopropionase is an
enzyme that in humans is encoded by the UPB1gene.[5][6]
This gene encodes a protein that belongs to the CN hydrolase family. Beta-ureidopropionase catalyzes the last step in the pyrimidine degradation pathway. The pyrimidine bases
uracil and
thymine are degraded via the consecutive action of
dihydropyrimidine dehydrogenase (DHPDH),
dihydropyrimidinase (DHP) and
beta-ureidopropionase (UP) to
beta-alanine and
beta-aminoisobutyric acid, respectively. UP deficiencies are associated with N-carbamyl-beta-amino aciduria and may lead to abnormalities in neurological activity.[6]
Interactive pathway map
Click on genes, proteins and metabolites below to link to respective articles.[§ 1]
Thomas HR, Ezzeldin HH, Guarcello V, et al. (2008). "Genetic regulation of beta-ureidopropionase and its possible implication in altered uracil catabolism". Pharmacogenet. Genomics. 18 (1): 25–35.
doi:
10.1097/FPC.0b013e3282f2f134.
PMID18216719.
S2CID10940058.
Thomas HR, Ezzeldin HH, Guarcello V, et al. (2008). "Genetic regulation of dihydropyrimidinase and its possible implication in altered uracil catabolism". Pharmacogenet. Genomics. 17 (11): 973–87.
doi:
10.1097/FPC.0b013e3282f01788.
PMID18075467.
S2CID23490646.
van Kuilenburg AB, Meinsma R, Assman B, et al. (2007). "Genetic analysis of the first 4 patients with beta-ureidopropionase deficiency". Nucleosides Nucleotides Nucleic Acids. 25 (9–11): 1093–8.
doi:
10.1080/15257770600956870.
PMID17065070.
S2CID34904943.
Naguib FN, el Kouni MH, Cha S (1985). "Enzymes of uracil catabolism in normal and neoplastic human tissues". Cancer Res. 45 (11 Pt 1): 5405–12.
PMID3931905.